Dublin, April 18, 2023 (GLOBE NEWSWIRE) -- The "Hormone Replacement Therapy (HRT): Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Hormone Replacement Therapy (HRT) estimated at US$24.5 Billion in the year 2022, is projected to reach a revised size of US$40.1 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2022-2030.
Estrogen Hormone Replacement Therapy, one of the segments analyzed in the report, is projected to record a 6.4% CAGR and reach US$21.9 Billion by the end of the analysis period.
Taking into account the ongoing post pandemic recovery, growth in the Human Growth Hormone Replacement Therapy segment is readjusted to a revised 7.5% CAGR for the next 8-year period.
The U.S. Market is Estimated at $7.2 Billion, While China is Forecast to Grow at 5.9% CAGR
The Hormone Replacement Therapy (HRT) market in the U.S. is estimated at US$7.2 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$7 Billion by the year 2030 trailing a CAGR of 5.9% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 5.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.
Select Competitors (Total 47 Featured) -
- Abbott Laboratories
- Allergan Plc
- Bayer AG
- Novartis AG
- Noven Pharmaceuticals Inc.
- Novo Nordisk A/S
- Pfizer Inc.
- TherapeuticsMD Inc.
What`s New for 2023?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 276 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $24.5 Billion |
| Forecasted Market Value (USD) by 2030 | $40.1 Billion |
| Compound Annual Growth Rate | 6.4% |
| Regions Covered | Global |
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- An Introduction to Menopause and Hormone Replacement Therapy
- Recent Market Activity
- The HRT Controversy - An Insight
- Newer Studies Challenge WHI Findings and Re-establish Safety of HRT
- Revised Recommendations of the NAMS and Endocrine Society
- IMS Consensus Guidelines Paving Way for More Clarity of HRT
- The Regional Divide
- Increasing Number of Menopausal Women - A Major Market Driver
- New Bioidentical Drugs Serve Unmet Market Needs
- Generic Incursion in Hormone Replacement Therapy - List of Drugs With and Without Approved Generic Versions
- Intense Competition Marks the Global HRT Market
- The Premarin Saga
- Estrace Cream Drives Revenue Gains in Allergan's HRT Portfolio
- Hormone Replacement Therapy (HRT) - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Unmet Needs in Combination Therapies for HRT drive Research for New Medicines
- Topical Estrogens - More Safe and Effective
- Transdermal HRT Products Present Exciting Opportunities
- Phytoestrogens - The New Panacea for Menopausal Symptoms?
- Diet Link to Menopause Symptoms Raises Interest
- Impact of Soy and Other Phytoestrogens - A Reality Check
- EstroG - A Successful Herbal Health Supplement in Alleviating Menopausal Symptoms
- The Growing Buzz around Bioidentical Drugs
- Bio-identical Hormones - A Natural and Safe Substitute to Synthetic HRT?
- Pellet Therapy - A New Innovation Downsizes Conventional Issues with Bioidentical HRT
- Direct-to-Consumer Advertising for HRT - A Mixed Bag
- Estriol: The Next Generation Estrogen Therapy?
- What Makes Estriol Work?
- Topical Estriol - More Promising in Safety
- Estriol - Used More Commonly Outside the US
- Entry of Generics Threatens Market Growth Prospects
- Are Non-Hormonal Therapies A Threat to HRT?
- Earlier Failures Induce Lethargy in Non-Hormonal Therapies
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/7lv1lr
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
